5-Benzyloxy-2-(2,5-dimethylpyrrol-1-yl)pyridine, 95.0%, 5g

3-Amino-1-piperidin-1-yl-propan-1-one x HCl, 98.0%, 250mg

Bis[2-[(oxo)diphenylphosphino]phenyl] Ether (purified by sublimation)>99.0%(HPLC)1g

3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)uridine>95.0%(HPLC)(qNMR)1g

(3aR,6aS)-tetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,3aH)-dione hydrochloride hydrate, 95.0%, 250mg

Feuille de cuivre (OFHC) 99,95+% 0,25 x 50 x 50 mm 1 pc

Thalidomide-O-PEG4-azide, 250mg

1,5-Dichloro-3-fluoro-2-iodobenzene, 95+%, 1g

4,7,10,13-Tetraoxahexadecane-1,16-dioic acid, 97%, 1g

(3-Fluoro-4-morpholinophenyl)boronic acid, 95.0%, 250mg

Morpholine-4-carbonyl chloride, 95.0%, 10g

4-Ethoxy-3-fluoro-5-(trifluoromethyl)benzaldehyde, 98%, 250mg

4-(Hydroxymethyl)picolinic acid, 97%, 5g